Fisher & Paykel Healthcare Corporation

Fisher & Paykel Healthcare is a global leader in the design, manufacturing and marketing of medical devices, with a focus on innovative products for respiratory care, acute care, surgery and obstructive sleep apnoea.

Products are manufactured in NZ and Mexico and are primarily sold to hospitals and healthcare facilities around the world through an extensive distribution network.

F&P is listed on both the NZX and ASX and is one of the largest listed companies on the NZX in terms of market capitalisation. The company employs over 5,000 people and is a leader in research and development, investing more than $100 million a year into innovation. Lewis Gradon took over as CEO in 2016.

Company Details

Registered Office: 15 Maurice Paykel Place, East Tamaki, Auckland 2013

Postal Address: PO Box 14348, Panmure, Auckland 1741

Telephone: +64 9 574 0100

Facsimile: +64 9 574 0158

Website: http://www.fphcare.co.nz/

First Listed: 01/11/1979

Balance Date: 31 March

AGM: 21/08/2025

Directors and Executives

Mark Cross

Independent Non-Executive Director

Michael Daniell

Director

Lewis Gradon

Chief Executive Officer and Managing Director

Raelene Leonard

General Counsel / Company Secretary

Lisa McIntyre

Independent Non-Executive Director

Graham McLean

Independent Non-Executive Director

Neville Mitchell

Chair

Cather Simpson

Independent Non-Executive Director

Lyndal York

Chief Financial Officer

Announcements

Title	Date	Type
SPH Notice - Pinnacle Investment Management Group Limited	Wed, Nov 26 2025 04:27 pm	SHINTR
FPH delivers strong growth for the first half	Wed, Nov 26 2025 08:30 am	HALFYR
SPH Notice - Hyperion Asset Management Limited	Thu, Nov 13 2025 08:30 am	SHINTR
SPH Notice - AustralianSuper Pty Ltd	Mon, Nov 10 2025 08:45 am	SHINTR
SPH Notice – Hyperion Asset Management Limited	Mon, Oct 20 2025 05:26 pm	SHINTR
FPH to announce half year results on 26 November 2025	Tue, Oct 14 2025 01:40 pm	GENERAL
Ongoing Disclosure Notice - Ordinary Shares	Thu, Oct 02 2025 10:52 am	SHINTR
Capital Change Notice - North America ESPP	Thu, Oct 02 2025 10:48 am	SECISSUE
Ongoing Disclosure Notices - Options, PSRs, Ordinary Shares	Thu, Sep 18 2025 11:13 am	SHINTR
Ongoing Disclosure Notices - Options, PSRs, Ordinary Shares	Tue, Sep 16 2025 01:44 pm	SHINTR

Major Holdings Announcements

Date	Name	No. Held	%	Current
30/07/25	AustralianSuper Pty Ltd	29,438,089	-	5.02
07/07/25	Pinnacle Investment Management Grou	29,745,515	-	5.07
14/04/25	Pinnacle Investment Management Grou	29,185,551	5.16	4.98
04/03/25	Hyperion Asset Management Limited	28,698,823	6.09	4.90
28/02/25	Mitsubishi UFJ Financial Group, Inc	29,158,813	5.17	4.98
03/08/21	The Vanguard Group, Inc.	21,144,194	5.26	3.67
13/07/21	BlackRock, Inc. and related bodies	37,908,016	5.01	6.58
17/08/20	The Capital Group Companies, Inc.	27,621,429	5.36	4.80
04/12/17	Bennelong Funds Management Group Pt	28,250,795	5.00	4.95
22/06/17	Northcape Capital Pty Limited	28,174,622	5.01	4.96

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
13/06/25	Graham Andrew McLean	3,900	-	-	-
05/06/25	Lyndal Jane York	22,614	-	-	-
07/04/25	Lewis George Gradon	574,224	-	-	-
07/04/25	Andrew Grant Niccol	3,559	-	-	-
01/10/24	Andrew Mark Cross	4,000	-	-	-
26/09/24	Miriam Cather Simpson	1,950	-	-	-
15/07/24	Neville John Mitchell	7,445	-	-	-
15/07/24	Lisa Margaret McIntyre	13,564	-	-	-
15/07/24	Scott A. St John	22,752	-	-	-
20/12/23	Donal ODwyer	73,418	-	-	-
06/07/20	Michael Grenfell Daniel	900,168	-	-	-
15/10/19	Geraldine Celia McBride	1,262	-	-	-
08/01/19	Antony John Carter	76,102	-	-	-
12/07/18	Arthur Morris	29,695	-	-	-
29/12/17	Antony George Barclay	150,000	-	-	-
21/12/17	Anthony Beverley	74,962	-	-	-
01/06/17	Philippa Greenwood	3,800	-	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 04/09/2025